下呼吸道感染患者支气管肺泡灌洗液定量培养及临床分析
DOI:
作者:
作者单位:

1.淮安市第一人民医院分院检验科;2.江苏省人民医院

作者简介:

通讯作者:

中图分类号:

基金项目:


Quantitative culture and clinical analysis of bronchoalveolar lavage fluid in patients with lower respiratory tract infection
Author:
Affiliation:

1.Laboratory Department of Huaian First People'2.'3.s Hospital;4.Department of Laboratory Medicine, the First Affiliated Hospital of Nanjing Medical University

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:探讨下呼吸道感染患者支气管肺泡灌洗液病原菌分布及对常用抗菌药物耐药性分析,为临床用药提供合理依据。方法:回顾性分析南京医科大学第一附属医院2018年下呼吸道感染患者支气管肺泡灌洗液定量分离培养结果及临床资料。结果:178例患者共分离病原菌197株,其中社区获得性肺炎(Community acquired pneumonia,CAP)101 例(56.7%),医院获得性肺炎(Hospital acquired pneumonia, HAP)77 例 (43.3%),主要来源于重症监护病房(30.5%)、老年医学科(29.5%)、呼吸与危重症医学科(26.4%)。HAP患者以革兰阴性菌为主,占89.5%,CAP患者也以革兰阴性菌为主,但比例低于HAP患者,占77.5%。分离到的病原菌中,革兰阴性菌163株,占82.7%,排在前3位的是鲍曼不动杆菌(71株,36.2%)、铜绿假单胞菌(34株,17.3%)和肺炎克雷伯菌(28株,14.3%);真菌23株,占9.6%,念珠菌属16株,曲霉菌4株,糠皮马拉色菌1株;革兰阳性菌13株,占6.6%,主要为金黄色葡萄球菌(10株,5.0%)。鲍曼不动杆菌对亚胺培南、美罗培南耐药率为98.6%,铜绿假单胞菌对亚胺培南、美罗培南耐药率分别为29.4%、23.5%,肺炎克雷伯菌对亚胺培南、美罗培南耐药率达57.1%。10株金黄色葡萄球共检出6株甲氧西林耐药金黄色葡萄球菌(MRSA), 检出率为60%,未检出对万古霉素、利奈唑胺耐药的金黄色葡萄球菌。结论:支气管肺泡灌洗液常见致病菌为革兰阴性杆菌,各病原菌耐药情况严重。临床应严格按照药敏结果合理用药,降低肺部感染的发生率。

    Abstract:

    Objective To investigate the distribution and antimicrobial resistance of pathogens in bronchoalveolar lavage fluid (BALF) of patients with lower respiratory tract infection ,and provide basis for rational choice of antimicrobial agents in clinic.Methods Retrospectively analyse the results and clinical data of quantitative isolation and culture of bacteria and antimicrobial resistance in bronchoalveolar lavage fluid of the First Affiliated Hospital of Nanjing Medical University during 2018. Results A total of 197 strains of pathogenic bacteria were isolated from 178 patients. 101 cases (56.7%) of community acquired pneumonia(CAP) and 77 cases (43.3%) of hospital acquired pneumonia(HAP) were mainly from intensive care unit (30.5%), geriatrics (29.5%) and respiratory and critical care medicine (26.4%).Gram-negative bacteria accounted for 89.5% of HAP patients and Gram-negative bacteria accounted for 77.5% of CAP patients, but the proportion was lower than that of HAP patients.Gram-negative bacteria accounted for 82.7%(163/197).The top three pathogens were Acinetobacter baumannii (34.1%,71/208), Pseudomonas aeruginosa (17.3%,36/208) and Klebsiella pneumoniae (14.0%,29/208)..Fungi accounted for 9.6%(21/197), including16 strains of Candida, 4 strains of Aspergillus and 1 strain of Malassezia furfur.Gram-positive bacteria accounted for 6.6%(13/197), mainly Staphylococcus aureus (5.0%,10/197).The resistance rates of Acinetobacter baumannii to imipenem and meropenem were 98.6%. The resistance rates of Pseudomonas aeruginosa to imipenem and meropenem were 29.4% and 23.5% respectively. The resistance rates of Klebsiella pneumoniae to imipenem and meropenem were 57.1%.Six methicillin-resistant Staphylococcus aureus (MRSA) strains were detected from 10 strains of Staphylococcus aureus with a detection rate of 60%.Staphylococcus aureus resistant to vancomycin and linezolid was not detected. Conclusion The common pathogenic bacteria in bronchoalveolar lavage fluid are Gram-negative bacteria, and the drug resistance of each pathogen is serious.n clinic, rational drug use should be strictly based on drug sensitivity results to reduce the incidence of pulmonary infection.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2019-09-25
  • 最后修改日期:2020-04-13
  • 录用日期:2020-09-07
  • 在线发布日期:
  • 出版日期:
关闭